Chuchu Lin
Overview
Explore the profile of Chuchu Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
104
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng Y, Ye Z, Xie Y, Du X, Song S, Ding X, et al.
Clin Transl Oncol
. 2023 Dec;
26(6):1357-1367.
PMID: 38145428
Purpose: To investigate the potential clinical importance of continuing immunotherapy beyond progression in patients with advanced non-small-cell lung cancer (aNSCLC). Methods: The data of patients with aNSCLC who experienced progressive...
2.
Shi Z, Luo M, Huang Q, Ding C, Wang W, Wu Y, et al.
Nat Commun
. 2023 Oct;
14(1):6567.
PMID: 37848496
Human serum albumin (HSA) based drug delivery platforms that feature desirable biocompatibility and pharmacokinetic property are rapidly developed for tumor-targeted drug delivery. Even though various HSA-based platforms have been established,...
3.
Chen T, Zeng W, Liu Y, Yu M, Huang C, Shi Z, et al.
Small
. 2023 Aug;
19(33):e2305389.
PMID: 37587098
No abstract available.
4.
Lin C, Huang C, Shi Z, Ou M, Sun S, Yu M, et al.
Acta Pharm Sin B
. 2022 Dec;
12(12):4472-4485.
PMID: 36561996
Hydrogen sulfide (HS) is the most recently discovered gasotransmitter molecule that activates multiple intracellular signaling pathways and exerts concentration-dependent antitumor effect by interfering with mitochondrial respiration and inhibiting cellular ATP...
5.
Chen T, Zeng W, Liu Y, Yu M, Huang C, Shi Z, et al.
Small
. 2022 Jun;
18(29):e2202964.
PMID: 35717674
Nanocatalytic medicine is a burgeoning disease treatment model with high specificity and biosafety in which the nanocatalyst is the core of driving catalytic reaction to generate therapeutic outcomes. However, the...
6.
Oxidative stress-amplified nanomedicine for intensified ferroptosis-apoptosis combined tumor therapy
Yu M, Yu J, Yi Y, Chen T, Yu L, Zeng W, et al.
J Control Release
. 2022 May;
347:104-114.
PMID: 35513212
Ferroptosis, as an effective sensitizer for apoptosis-based cancer treatments, has been elucidated to rely on high levels of intracellular oxidative stress mediated by the accumulation of reactive oxygen species (ROS)....
7.
Ou M, Lin C, Wang Y, Lu Y, Wang W, Li Z, et al.
J Control Release
. 2022 Apr;
345:755-769.
PMID: 35381273
The hypoxic tumor microenvironment is one of most major hurdles restraining the anti-tumor efficiency of photodynamic therapy (PDT). Herein, active photosynthetic Chlorophyceae (Chlorella, Chl) functionalized with black phosphorus nanosheets (BPNSs)...
8.
Shi Z, Tang J, Lin C, Chen T, Zhang F, Huang Y, et al.
Drug Deliv
. 2022 Feb;
29(1):624-636.
PMID: 35174748
Chemodynamic therapy (CDT) by triggering Fenton reaction or Fenton-like reaction to generate hazardous hydroxyl radical (•OH), is a promising strategy to selectively inhibit tumors with higher HO levels and relatively...
9.
Lin C, Yang X, Li H, Zou Y, Mohammad I, Rong H, et al.
Nanoscale
. 2021 Apr;
13(13):6605-6623.
PMID: 33885540
Mitochondria play a central role in cancer progression and tumor metastasis, and nanomedicines targeting mitochondria have emerged as a promising strategy for tumor therapy. However, mitochondria targeting strategies have not...
10.
Zhang M, Li J, Lu Y, Wu W, Wu J, Xu Y, et al.
Infect Drug Resist
. 2021 Apr;
14:1415-1422.
PMID: 33880046
Background: ST11 is the most prevalent sequence type of clinical in China. Methods: We investigated the characteristics of the ST11 subclones using core genome multi-locus sequence typing (cgMLST). Ninety-three carbapenemase-producing...